Funding
← Back to your selection

Novo Holdings

Activity from announced rounds

Activity in this selectionNov 30, 2022 · Nov 1, 2022

Novo Holdings manages the Novo Nordisk Foundation’s investment assets and invests in healthcare and life sciences across development stages.

Investment focus

The foundation-owned holding and investment company combines a broad long-term asset portfolio with dedicated healthcare and life-sciences investment teams. Its activities include seed, venture, planetary health and principal investments.

Activity recorded by RoundOS

Recorded financing includes AnaCardio’s heart-failure drug development, Adcendo’s antibody-drug conjugates, Terremoto’s small-molecule programs and Crystalys’ gout treatment candidate. These entries show selected therapeutic investments in the database, spanning different disease areas and clinical programs.

Sources
Rounds participated in
1
Confirmed lead rounds
1
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$4M
1 disclosed · full round size, not this investor’s share

By stage

Seed1

By primary sector

Biotech1

By country

Denmark1

Rounds

1 in this selection